In Vivo Research Associate — Contract (Kidney Focus)

Renasant Bio; Berkeley (CA); On-site; USD 52,982 - 59,581; Full time

Benefits offered by this job

Health benefits for contractors

Job summary

A leading biomedical company is seeking a motivated Contract Research Associate to support in vivo research for kidney diseases. Responsibilities include maintaining transgenic mouse colonies, performing dosing and blood collection, and collaborating with scientists on therapeutic evaluations. The ideal candidate will have a B.Sc. degree and experience in preclinical research. This position offers an opportunity to advance vital therapies and is contract-based with potential health benefits.

Qualifications

• 1-2 years of hands-on experience in preclinical research or equivalent experience.
• Experience with dosing techniques (e.g., IV, IP, SC), blood/tissue collection a plus.
• Demonstrated experience in managing transgenic mouse colonies.

Responsibilities

• Collaborate with scientists to evaluate therapeutic candidates using mouse models.
• Oversee mouse colonies, including breeding and inventory tracking.
• Perform routine in vivo tasks, including dosing and sample collection.
• Monitor animal health and ensure compliance with ethical standards.
• Provide documentation of experimental protocols and observations.
• Collaborate with multidisciplinary teams on study outcomes.
• Adapt to the evolving needs of the team.

Skills

Proficiency in rodent handling

Strong interpersonal skills

Attention to detail

Ability to manage multiple tasks

Education

B.Sc degree in relevant scientific field

Job description

A leading biomedical company is seeking a motivated Contract Research Associate to support in vivo research for kidney diseases. Responsibilities include maintaining transgenic mouse colonies, performing dosing and blood collection, and collaborating with scientists on therapeutic evaluations. The ideal candidate will have a B.Sc. degree and experience in preclinical research. This position offers an opportunity to advance vital therapies and is contract-based with potential health benefits.